Last reviewed · How we verify

NCT03153995

Alveolar Ridge Augmentation Following Self-Inflating Soft Tissue Expander

Completed NA Last updated 1 December 2020
What this trial tests

NA trial testing soft tissue expansion in Horizontal Ridge Deficiency in 16 participants. Completed in 1 November 2020.

Timeline
1 November 2017
Primary endpoint
1 March 2020
1 November 2020

Quick facts

Lead sponsorAin Shams University
PhaseNA
StatusCompleted
Study typeINTERVENTIONAL
Allocationrandomized
Designparallel
Maskingsingle
Primary purposetreatment
Enrollment16
Start date1 November 2017
Primary completion1 March 2020
Estimated completion1 November 2020
Sites1 location across Egypt

Drugs / interventions tested

Conditions studied

Sponsor

Ain Shams University

Who can join

Adults 20 to 60, any sex, with Horizontal Ridge Deficiency. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

The objective of this study will be to assess and compare between sub-periosteal self- inflating osmotic tissue expanders used as preparatory surgery before alveolar ridge augmentation and periosteal releasing incision using autogenous onlay block bone graft. The assessment and comparison will be based on: 1. Change in edentulous alveolar ridge in bucco-lingual dimension after alveolar ridge augmentation. 2. Quantity of the soft tissue obtained after soft tissue expansion.

Publications & conference data

No peer-reviewed publications indexed yet for this trial. Completed trials usually publish results within 12-18 months.

Verify or expand the search:

Other recruiting trials for Horizontal Ridge Deficiency

Currently open trials in the same condition.

Other Ain Shams University trials

Trials by the same sponsor.

Verify against primary sources

Data sources for this page

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT03153995.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing